Zavondemstat

N/A

Report date: 2024/12/16 13:16:02
NMEFirst In Class

Base Information

Drug NameZavondemstat
Drug Alias NameTACH-101TACH101QC-8222QC8222
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific demethylase 4 inhibitors
TargetsLysine-specific demethylase 4
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol Myers Squibb Srlcompany
China Registration ClassN/A

Develop Information

Active CompaniesTachyon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A